Home›Companies›Biotech & Pharma›Foldax

Foldax, Inc.

Updated Oct 27, 2026·Latest SEC filing Nov 7, 2023·Suggest an edit

About Foldax

Foldax is a private company based in Salt Lake City, Utah. It has reported $23,740,118 raised in ten offerings on Form D since March 2014.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Oct 18, 2023Nov 7, 2023$7,000,000target not set10$700KEquityRule 506(b)Form D ↗
Not yetJan 13, 2022$0of $15.0M target0—Debt, OptionsRule 506(b)Form D ↗
Dec 12, 2018Dec 19, 2018$10,300,118fully sold15$686KEquityRule 506(b)Form D ↗
Apr 3, 2017May 12, 2017$300,000of $9.0M target1$300KEquity, DebtRule 506(b)Form D ↗
Jul 15, 2016Jul 26, 2016$3,075,000fully sold9$341KEquityRule 506(b)Form D ↗
Aug 28, 2015Sep 8, 2015$2,500,000fully sold1$2.5MEquityRule 506(b)Form D ↗
Jun 8, 2015Jun 16, 2015$350,000of $1.5M target2$175KEquity, DebtRule 506(b)Form D ↗
Aug 14, 2014Aug 21, 2014amended Aug 21, 2014$50,000of $4.7M target1$50,000Debt, OptionsRule 506(b)Form D/A ↗1 earlier filing
Mar 26, 2014Apr 21, 2014$150,000of $1.5M target3$50,000Equity, DebtRule 506(b)Form D ↗
Feb 26, 2014Mar 18, 2014$15,000fully sold2$7,500Equity, Debt, Securities on exerciseRule 506(b)Form D ↗
Total, ten offerings$23,740,118

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Foldax's Form D filed Nov 7, 2023.

Scott Huennekens
Scott Huennekens
Director
Also a chairman of the board at Elucid and a director at Q'Apel Medical.
KC
Ken Charhut
Director
JD
Jim Demetriades
Director
Also a director at Linnaeus Therapeutics and a chairman at Provivi.
SR
GW
GC
Greg Casciaro
Executive officer and director
BH
Brant Heise
Director

Earlier filings also listed Renee Masi (director, last listed Jan 2022), Morteza Gharib (director, last listed Jan 2022), Mory Gharib (director, last listed Dec 2018) and Frank Maguire (executive officer and director, last listed Dec 2018).

Sources

  1. SECFoldax, Inc. Form D, filed Aug 21, 2014
  2. SECFoldax, Inc. filing history